Related Experiment Videos
Isoproterenol-induced hypertrophy may result in distinct left ventricular changes
Clinical and Experimental Pharmacology & Physiology
|June 1, 2000
Summary
Isoproterenol (ISO) induced myocardial hypertrophy is not uniform across all subjects. Some rats showed impaired relaxation and reduced force generation, suggesting necrosis and fibrosis may occur alongside hypertrophy.
Area of Science:
- Cardiology
- Physiology
- Pathology
Background:
- Myocardial hypertrophy is a common cardiac response to various stimuli.
- Isoproterenol (ISO) is frequently used to induce experimental myocardial hypertrophy.
- The uniformity of ISO-induced hypertrophy and its functional consequences require further investigation.
Purpose of the Study:
- To analyze the potential lack of uniformity in isoproterenol (ISO)-induced myocardial hypertrophy.
- To investigate the differing functional characteristics within ISO-treated groups.
- To explore underlying pathological mechanisms contributing to heterogeneity.
Main Methods:
- Twenty rats were treated with isoproterenol (0.3 mg/kg over 8 days).
- Hearts were isolated and data analyzed for isovolumic conditions.
- Groups were categorized (H1, H2) based on ventricular distensibility; control group (C) for comparison.
Main Results:
- Significant differences in myocardial mass were observed: H1 > H2 > C.
- Group H2 exhibited impaired relaxation (longer relaxation constant) compared to H1.
- Maximum developed circumferential stress was reduced in H2 compared to C and H1.
Conclusions:
- Isoproterenol-induced myocardial hypertrophy is not a homogeneous process.
- Some ISO-treated animals may experience myocardial necrosis and fibrosis, impacting cardiac function.
- This heterogeneity may explain discrepancies in literature regarding this experimental model.